Epigenetic remodeling combined with photodynamic therapy elicits anticancer immune responses

Malgorzata Wachowska1, Magdalena Gabrysiak1, Jakub Golab2

  • 1Department of Immunology; Center for Biostructure Research; Medical University of Warsaw; Warsaw, Poland.

Oncoimmunology
|July 25, 2014
PubMed

Insights

Photodynamic therapy combined with epigenetic remodeling can enhance anti-tumor immunity. This approach restores tumor-associated antigen expression, leading to a stronger and lasting immune response against cancer cells.

Area of Science:

  • Immunology
  • Oncology
  • Epigenetics

Background:

  • Photodynamic therapy (PDT) can induce immunity against tumor cells expressing tumor-associated antigens (TAAs).
  • Cancer cells can evade immune detection by epigenetically silencing TAAs.
  • DNA methyltransferase inhibitors can restore TAA expression.

Purpose of the Study:

  • To investigate the combination of epigenetic remodeling with 5-aza-2'-deoxycytidine (5-aza-dC) and PDT.
  • To determine if this combination can enhance antitumor immunity.

Main Methods:

  • Utilized 5-aza-dC to demethylate and restore silenced TAA expression.
  • Applied PDT to induce immune responses against TAA-expressing tumor cells.

Main Results:

  • The combination therapy demonstrated the ability to restore TAA expression in cancer cells.
  • Epigenetic remodeling followed by PDT resulted in robust and durable antitumor immunity.

Conclusions:

  • Combining epigenetic remodeling with 5-aza-dC and PDT is a promising strategy.
  • This approach can overcome TAA silencing and elicit potent, long-lasting anti-cancer immune responses.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K